Concord Biotech Ltd - 543960 - Update On The USFDA Inspection At The Company''s API Facility At Dholka

Concord Biotech Ltd.

NSE: CONCORDBIO | BSE: 543960 | ISIN: INE338H01029 | Industry: Biotechnology
| Expensive Performer

1780.4000 -41.40 (-2.27%)

NSE Jun 24, 2025 15:31 PM

33.17% Fall from 52W High

Volume: 259.7K

Concord Biotech Ltd.

24 Jun 2025, 01:40PM

1780.40

-2.27%

Company Update

Concord Biotech Ltd - 543960 - Update On The USFDA Inspection At The Company''s API Facility …

BSE India

Concord Biotech limited receives Establishment Inspection Report (EIR) for it''s API facility at Dholka

More from Concord Biotech Ltd.

Recommended

Market closes higher, Bondada Engg bags a Rs 836 crore order in Tamil Nadu

Trendlyne Marketwatch | 24 Jun 2025, 03:56PM

IPOs This Week: Arisinfra and Five Others to List; Eighteen New Issues

| 23 Jun 2025, 04:49PM

Five Interesting Stocks Today - June 20, 2025

The Baseline | 20 Jun 2025